Literature DB >> 30656393

Probiotic effects of marine Debaryomyces hansenii CBS 8339 on innate immune and antioxidant parameters in newborn goats.

Miriam Angulo1, Martha Reyes-Becerril1, Ramón Cepeda-Palacios2, Dariel Tovar-Ramírez1, María Ángeles Esteban3, Carlos Angulo4.   

Abstract

Several marine Debaryomyces hansenii strains have shown probiotic effects on aquatic animals, and D. hansenii-derived β-glucans have recently provided immunostimulant effects on goat leukocytes. This study assessed the probiotic effects of live yeast D. hansenii CBS 8339 on newborn goats administered orally, and subsequently challenged in vitro with Escherichia coli. D. hansenii CBS 8339 demonstrated the capacity to survive gastrointestinal tract conditions (bile salts and acid pH tolerance) and adhere to goat intestine. Twelve Saanen × Nubian crossbred newborn goats (2.9 ± 0.47 kg) were fed with a controlled diet or D. hansenii (0.7 g/kg body weight per day)-supplemented milk for 30 days. Blood samples of newborn goats were taken at days 15 and 30, and peripheral blood leukocytes were isolated for bacterial challenge, and immunological and antioxidant analyses. Despite cell viability was higher in leukocytes of goat kids fed with the yeast supplement, protection against E. coli challenge was not significantly affected. On the other hand, at day 15, oral administration of D. hansenii enhanced respiratory burst and catalase activity and increased superoxide dismutase activity after challenge. In contrast, at day 30, administration of the yeast supplement increased peroxidase activity and enhanced nitric oxide production and catalase activity after challenge. Finally, the yeast-supplemented diet upregulated the expression of the receptor genes TLR (2, 4, 6), modulator genes Raf.1, Syk, and Myd88, transcription factor gene AP-1, and cytokine genes IL-1β and TNF-α only at day 15 in leukocytes from unchallenged goat kids. These results demonstrated that a short time (15 days) of orally administering the probiotic D. hansenii CBS 8339 to newborn goats stimulated innate immune and antioxidant parameters and the expression of immune-related gene signaling pathways.

Entities:  

Keywords:  Immune innate response; Immune-associated pathways; Marine yeast; Newborn goats; Probiotics

Mesh:

Substances:

Year:  2019        PMID: 30656393     DOI: 10.1007/s00253-019-09621-5

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

Review 1.  Impact of Probiotics on Dairy Production Efficiency.

Authors:  Kirankumar Nalla; Naresh Kumar Manda; Harmeet Singh Dhillon; Santosh R Kanade; Namita Rokana; Matthias Hess; Anil Kumar Puniya
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

2.  Effect of Debaryomyces hansenii combined with Qiweibaizhu powder extract on the gut microbiota of antibiotic-treated mice with diarrhea.

Authors:  Guozhen Xie; Yi Wu; Tao Zheng; Kejia Shen; Zhoujin Tan
Journal:  3 Biotech       Date:  2020-02-20       Impact factor: 2.406

Review 3.  Innate Immunomodulation in Food Animals: Evidence for Trained Immunity?

Authors:  Kristen A Byrne; Crystal L Loving; Jodi L McGill
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

Review 4.  Recent advances in the application of probiotic yeasts, particularly Saccharomyces, as an adjuvant therapy in the management of cancer with focus on colorectal cancer.

Authors:  Roshanak Sambrani; Jalal Abdolalizadeh; Leila Kohan; Behboud Jafari
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

Review 5.  Exploring biotechnological and functional characteristics of probiotic yeasts: A review.

Authors:  B Shruthi; N Deepa; Rakesh Somashekaraiah; G Adithi; S Divyashree; M Y Sreenivasa
Journal:  Biotechnol Rep (Amst)       Date:  2022-02-28

6.  Planococcus maritimus ML1206 Isolated from Wild Oysters Enhances the Survival of Caenorhabditis elegans against Vibrio anguillarum.

Authors:  Ying-Xiu Li; Nan-Nan Wang; Yan-Xia Zhou; Chun-Guo Lin; Jing-Shan Wu; Xin-Qi Chen; Guan-Jun Chen; Zong-Jun Du
Journal:  Mar Drugs       Date:  2021-03-12       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.